ADTX: Gunggung utang perusahaan Aditxt Corp

Aditxt (ADTX) integrates diagnostics and treatment into a single digital circuit, yet a lack of pricing power and a reliance on new share issuances render its financial position critical, as confirmed by the quotes below on GURU.Markets, where the indicator stands at 0.00. The company's operations rely on US-based capacities for precision immunity analysis and the development of technologies to combat transplant rejection.

Aditxt operational successes and the company's debt financing dynamics reflect a balance between expansion and debt sustainability. This indicator aggregates short-term and long-term liabilities, allowing investors to assess bankruptcy risks or leverage efficiency, which is critical given the business's high dependence on external laboratory capacities and the technological stability of third-party vendors.